These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21188525)

  • 1. Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection.
    White DL; Richardson PA; Al-Saadi M; Fitzgerald SJ; Green L; Amaratunge C; Anand M; El-Serag HB
    Dig Dis Sci; 2011 Jun; 56(6):1835-47. PubMed ID: 21188525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients.
    Tyson GL; Richardson PA; White DL; Kuzniarek J; Ramsey DJ; Tavakoli-Tabasi S; El-Serag HB
    J Clin Gastroenterol; 2013 Jul; 47(6):545-52. PubMed ID: 23426443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males.
    White DL; Tavakoli-Tabasi S; Kanwal F; Ramsey DJ; Hashmi A; Kuzniarek J; Patel P; Francis J; El-Serag HB
    Aliment Pharmacol Ther; 2013 Jul; 38(1):28-37. PubMed ID: 23710689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.
    Khalaf N; White D; Kanwal F; Ramsey D; Mittal S; Tavakoli-Tabasi S; Kuzniarek J; El-Serag HB
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1521-31.e3. PubMed ID: 25777972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.
    White DL; Tavakoli-Tabasi S; Kuzniarek J; Pascua R; Ramsey DJ; El-Serag HB
    Hepatology; 2012 Mar; 55(3):759-68. PubMed ID: 21858849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.
    Cholet F; Nousbaum JB; Richecoeur M; Oger E; Cauvin JM; Lagarde N; Robaszkiewicz M; Gouérou H
    Gastroenterol Clin Biol; 2004 Mar; 28(3):272-8. PubMed ID: 15094677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
    Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
    Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finasteride and methadone use and risk of advanced hepatitis C related liver disease.
    White DL; Hashmi A; Ramsey DJ; Kuzniarek J; Tavakoli-Tabasi S; El-Serag HB
    Dig Dis Sci; 2012 Nov; 57(11):3004-10. PubMed ID: 22669204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
    BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].
    Coral G; de Mattos AA; de Mattos AZ; dos Santos DE
    Arq Gastroenterol; 2006; 43(4):265-8. PubMed ID: 17406752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis C: analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial.
    Yu L; Morishima C; Ioannou GN
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1661-6.e1-3. PubMed ID: 23707779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic steatosis in chronic hepatitis C: study of risk factors and relationship with the fibrosis stage].
    Antón MD; Roselló E; Gómez F; Paredes JM; López A; Moreno-Osset E
    Med Clin (Barc); 2009 Apr; 132(15):574-9. PubMed ID: 19368934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients.
    Liu Y; El-Serag HB; Jiao L; Lee J; Moore D; Franco LM; Tavakoli-Tabasi S; Tsavachidis S; Kuzniarek J; Ramsey DJ; White DL
    PLoS One; 2013; 8(12):e84407. PubMed ID: 24386373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
    Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
    Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
    Hu KQ; Currie SL; Shen H; Cheung RC; Ho SB; Bini EJ; McCracken JD; Morgan T; Bräu N; Schmidt WN; Jeffers L; Wright TL;
    Dig Dis Sci; 2007 Feb; 52(2):570-8. PubMed ID: 17226072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.